Several multinationals increased their investments in the Russian pharma market in 2011 including Novartis, which began construction of a manufacturing facility in St. Petersburg and AstraZeneca which began constructing a new manufacturing plant in the Kaluga region.
Market Size in 2010: $18.7 billion
Population: 142 million
Industry Makeup: Most countries have a several multinationals operating within
Branded vs. Generic: Russia's market has been dominated by locally produced generics but there is a growing demand for more branded generics from multinational companies.
Distribution: In 2010, the top 10 distributors dominated 90 percent of distribution.
Main Customers: Hospitals, managed care organizations, state agencies, drug retailers.
Estimated growth by 2015: 10 to 12 percent
Sources: Espicom, IMS Health, Russian-American Business, DSM Group